Symposium Speaker: Brenda Finucane, MS, LGC

Brenda Finucane, MS, LGC, is Professor and Associate Director of Geisinger Health System's Autism and Developmental Medicine Institute.  Finucane is a genetic counselor, and her education and career have straddled research and the clinic.  Her clinical and research activities have focused on genetic causes of developmental brain disorders, including autism and intellectual disability.  Finucane's early work focused on the behavioral and cognitive consequences of the fragile X syndrome, Smith-Magenis, and 15q duplication, among other syndromes.  At Geisinger in her current position, Finucane and her team study the family genetic background and its impact on phenotypes for several syndromes including the fragile X syndrome, sex chromosomal abnormalities, and the 22q11.2 deletion syndrome.  Ms. Finucane has a particular interest in translating knowledge about genetic diagnoses into practical strategies that enhance healthcare, behavioral, and educational interventions for children and adults.  She is widely published and has been in leadership roles in professional and advocacy organizations throughout her career, including a term as president of the National Society of Genetic Counselors.

Recent Publications

  1. Finucane, B, Savatt, JM, Shimelis, H, Girirajan, S, Myers, SM. Birt-Hogg-Dubé symptoms in Smith-Magenis syndrome include pediatric-onset pneumothorax. Am J Med Genet A 2021; 185 (6): 1922-1924. PubMed PMID:33666332 .
  2. Finucane, BM, Ledbetter, DH, Vorstman, JA. Diagnostic genetic testing for neurodevelopmental psychiatric disorders: closing the gap between recommendation and clinical implementation. Curr Opin Genet Dev 2021; 68 : 1-8. PubMed PMID:33434711 PubMed Central PMC8205959.
  3. Finucane, BM, Myers, SM, Martin, CL, Ledbetter, DH. Long overdue: including adults with brain disorders in precision health initiatives. Curr Opin Genet Dev 2020; 65 : 47-52. PubMed PMID:32544666 PubMed Central PMC7736248.
  4. Wain, KE, Palen, E, Savatt, JM, Shuman, D, Finucane, B, Seeley, A, Challman, TD, Myers, SM, Martin, CL. The value of genomic variant ClinVar submissions from clinical providers: Beyond the addition of novel variants. Hum Mutat 2018; 39 (11): 1660-1667. PubMed PMID:30311381 PubMed Central PMC6190575.
  5. Ajayi, OJ, Smith, EJ, Viangteeravat, T, Huang, EY, Nagisetty, NSVR, Urraca, N, Lusk, L, Finucane, B, Arkilo, D, Young, J et al.. Multisite Semiautomated Clinical Data Repository for Duplication 15q Syndrome: Study Protocol and Early Uses. JMIR Res Protoc 2017; 6 (10): e194. PubMed PMID:29046268 PubMed Central PMC5666222.
  6. Brendal, MA, King, KA, Zalewski, CK, Finucane, BM, Introne, W, Brewer, CC, Smith, ACM. Auditory Phenotype of Smith-Magenis Syndrome. J Speech Lang Hear Res 2017; 60 (4): 1076-1087. PubMed PMID:28384694 PubMed Central PMC5548078.
  7. Finucane, B, Lincoln, S, Bailey, L, Martin, CL. Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions. Prenat Diagn 2017; 37 (1): 37-42. PubMed PMID:27862088 .
  8. Liu, JA, Hagerman, RJ, Miller, RM, Craft, LT, Finucane, B, Tartaglia, N, Berry-Kravis, EM, Sherman, SL, Kidd, SA, Cohen, J et al.. Clinicians' experiences with the fragile X clinical and research consortium. Am J Med Genet A 2016; 170 (12): 3138-3143. PubMed PMID:27604509 .
  9. Finucane, B, Myers, SM. Genetic Counseling for Autism Spectrum Disorder in an Evolving Theoretical Landscape. Curr Genet Med Rep ; 4 : 147-153. PubMed PMID:27570713 PubMed Central PMC4982889.
Search PubMed

Brenda Finucane on Twitter

How the detection of rare genetic etiologies of neurodevelopmental psychiatric disorders like #autism can lead to more effective treatment, by @brenda_finucane, @dhledbetter, and @Jacob_Vorstman twitter.com/Jacob_Vorstman… Retweeted by Brenda Finucane

2/4 Without adequate collaboration between the two fields, "the implementation of genetic testing for NPD will continue to lag behind other areas of medicine". @dhledbetter @brenda_finucane @G2MH_Network @PGCgenetics In short, we need to move from this: Retweeted by Brenda Finucane

Great conference - honored to be invited as a speaker. @GeisingerADMI @GeneticCouns twitter.com/IPsychiatrie/s…

EnGagE Workshop – Principles of Psychiatric Genetic Counselling and Testing ipnp.paris5.inserm.fr/actualites/cpn… Le workshop aura lieu les 11 et 12 avril dans l'amphithéâtre de l'IPNP. Retweeted by Brenda Finucane

@AmyCurrySturm is knocking it out of the park in Atlanta with her #nsgc18 incoming presidential address 💪🏼 @GeneticCouns @GeisingerRsrch

@GCBrianne @Janet_LCGC Awww. Thanks Brianne! It’s amazing to see how far our profession has come.

This Women-Driven Field Is Changing Health Care | For Better | US News health.usnews.com/health-care/fo… #IAmAGeneticCounselor @GeneticCouns Retweeted by Brenda Finucane

@Marc_GeneDoc I bet Janet is sayin “speak for yourself about being old!”

Join me in thanking genetic counselors for the important role they play in healthcare. #IAmAGeneticCounselor thndr.me/HSHZ2s Retweeted by Brenda Finucane

Happy Genetic Counselor Awareness Day (from two oldies but goodies) #GeneticCounselors

test Twitter Media - Happy Genetic Counselor Awareness Day (from two oldies but goodies) #GeneticCounselors https://t.co/H2ihpzbEdi

Great video. Nice representation from @GeisingerRsrch Well done @brenda_finucane and @Janet_LCGC twitter.com/GeneticCouns/s… Retweeted by Brenda Finucane

@DivadRetsop Ha! Well, it's already got a name: Developmental Brain Dysfunction ncbi.nlm.nih.gov/pubmed/23518333 cc @ScottMyers20 - can manifest in many ways Retweeted by Brenda Finucane

Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome cell.com/neuron/fulltex… - very high risk! Retweeted by Brenda Finucane

Amazing work being done @GeisingerADMI on genetics of neurodevelopmental disorders! Now nearly 50% of cases have identified genetic cause Retweeted by Brenda Finucane

So excited that @GeisingerADMI will benefit. Let's make sure there's a fantastic turnout for this important event! twitter.com/GeisingerADMI/…

President Trump, you made a big mistake. By trying to divide us up by race, religion, gender and nationality you actually brought us closer. Retweeted by Brenda Finucane

‘Science’ has published 2 landmark genetic studies from @GeisingerRsrch & @Regeneron collaboration #DiscovEHR ow.ly/HAkU307mZJt Retweeted by Brenda Finucane

The Finucane Lab Website

Curriculum vitae